InvestorsHub Logo
Followers 22
Posts 899
Boards Moderated 0
Alias Born 07/24/2002

Re: None

Sunday, 01/09/2005 1:24:23 PM

Sunday, January 09, 2005 1:24:23 PM

Post# of 82595
This is VERY interesting. Mentions specifically Affymetrix, and the limitations of their mass array technology in gene expression. Scroll down the page, however, and you will see mention of Biofrontera:

BOBERG: I would say that few companies have the same high technological ability of gene expression as Global Genomics, although many companies do compete with Affymetrix in the microarray space. In the open system competitive space, there is one company called Biofrontera that uses their technology for in-house development, but have chosen not to market their technology for strategic reasons. There are few open gene expression systems with similar sensitivity and reliability as tangerine profiling.

Sounds like there is a market for the DEPD technology itself if Biofrontera/DNAPrint wish to pursue it.

Interesting audio interview on the subject, done on April 6, 2004 at this link:

http://64.233.167.104/search?q=cache:cFSCbA57X30J:www.wallstreetreporter.com/linked/GlobalGenomics.h....

Later,
W2P